Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
about
Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation.Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survivalNon-canonical NF-κB signaling pathway.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.The non-canonical NF-κB pathway in immunity and inflammation.Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells.CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.The NFKB Inducing Kinase Modulates Hematopoiesis During Stress.NF-κB in Hematological Malignancies.Analysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study
P2860
Q34624443-B1A5E7BD-1A4F-4916-A8AF-1ADF6B5AB39DQ34707404-FDA5922B-5022-42A6-AA56-3D2B09BE1C34Q35125212-1766943A-E2BF-4517-91FD-992E1B281C4BQ36370847-E03CFB43-881C-46C7-B953-BE82289A177CQ37822660-2A043BA6-68F6-4DD4-A9C2-321CE9D9AE11Q38182355-D46F2688-0303-4165-A607-1E93C877EFA3Q38988815-020DCE71-CC51-45FF-A669-4B5DBF981566Q39350735-1D66DC5C-0210-409E-B632-4B878B126EB4Q39468269-2AD1855C-0FA6-45E3-8014-0A8E714E619DQ40026531-0CCD783B-5603-4F80-A0D8-AFD4827BA2ACQ40177590-BB7E640D-31DD-4FED-8B38-42BE1056DB80Q40383844-1CC71110-1359-4566-BA93-DBA1172B3119Q50443743-5AB7A109-E55E-48A7-804A-2775C2ACDC4CQ54147337-38603A13-2D65-4B5C-805A-67FA0BE63C2CQ58698930-1DD8E7B9-1C4F-4096-BD3C-E3AF7D2C2571
P2860
Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Aberrant NF-kappaB2/p52 expres ...... 0-transformed rat fibroblasts.
@en
type
label
Aberrant NF-kappaB2/p52 expres ...... 0-transformed rat fibroblasts.
@en
prefLabel
Aberrant NF-kappaB2/p52 expres ...... 0-transformed rat fibroblasts.
@en
P2093
P2860
P356
P1433
P1476
Aberrant NF-kappaB2/p52 expres ...... 0-transformed rat fibroblasts.
@en
P2093
Kinji Itoh
Mizuho Nonaka
Ryouichi Horie
Shoji Yamaoka
Toshiki Watanabe
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208564
P407
P577
2005-06-01T00:00:00Z
P5875
P6179
1015857953